Selegiline protects against isoproterenol-induced myocardial ischemia injury: a potential mechanistic role of the PI3K/AKT/mTOR signaling pathway
Background and purpose: Selegiline, an irreversible monoamine oxidase B inhibitor, has been shown to have potential in reducing cell damage. The present study design focused on the cardioprotective effect of selegiline and its possible mechanism of action through phosphoinositide-3-kinase/serine-thr...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wolters Kluwer Medknow Publications
2025-07-01
|
| Seri Bilgileri: | Research in Pharmaceutical Sciences |
| Konular: | |
| Online Erişim: | https://journals.lww.com/10.4103/RPS.RPS_234_24 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|